DatePriceChangeVolume 24-11-18187.69$-0.81%445K 24-11-15189.23$-2.10%274K 24-11-14193.29$-1.11%213K 24-11-13195.45$+0.93%282K 24-11-12193.64$-5.56%335K Delayed Quote Nasdaq, November 19, 2024 at 04:00 pm EST More quotes Income Statement and Estimates ...
Delayed Quote Nasdaq, October 25, 2024 at 04:00 pm EDT More quotes Income Statement and Estimates More financial data Ratings Trading Rating Investor Rating ESG Refinitiv BMore Ratings Analysts' Consensus Sell Buy Mean consensus BUY Number of Analysts 22 Last Close Price 212.81USD Av...
11/01Barron'sDell Is Winning AI Server Market Share. Plus, Alphabet Cloud Growth, Shake Shack, and More Stocks. 11/01Nvidia to replace Intel in the Dow, underscoring downfall of an industry titan 11/01Barron'sBath & Body Works, Paramount Global, and More Stocks See Action From Activist ...
Revenue Per Share 29.652 Quarterly Revenue Growth 0.561 Return On Assets (0.1) Return On Equity (0.15) The market value of BeiGene is measured differently than its book value, which is the value of BeiGene that is recorded on the company's balance sheet. Investors also form their own op...
CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, today reported financial results for the fourth quarter and full year of 2021, recent bus...
SUMMIT, N.J. & BEIJING--(BUSINESS WIRE)--Celgene Corporation (NASDAQ:CELG)andBeiGene, Ltd. (NASDAQ:BGNE)entered into a strategic collaboration to develop and commercialize BeiGene’s investigational anti-programmed cell death protein 1 (PD-1) inhibitor, BGB-A317, for patients with solid tumor...
Current Price $135.98 NASDAQ: GILD Gilead Sciences Market Cap $106B Current Price $84.28 NASDAQ: EXEL Exelixis Market Cap $8B Current Price $26.44 Premium Investing Services Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium...
Each ADS represents 13 ordinary shares, par value $0.0001 per share. We will not receive any proceeds from the sale of ADSs by the selling shareholders. The ADSs are listed on the NASDAQ under the symbol "BGNE." The last reported sale price of the ADSs on the NASDAQ on November 16, ...
BeiGene, Ltd. (BGNE.NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock BeiGene, Ltd. | Nasdaq: BGNE | Nasdaq
Biotechnology Pharmaceuticals, Biotechnology & Life Sciences Health Care NASDAQ Biotechnology ARCA Biotechnology Cancer Fighters For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide. You can also try the Competition Analyzer module to analyze and compare many ba...